1 2

21 November 2016 EMA/QRD/752627/2016

6

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP)

7

Draft

3 4 5

Draft agreed by Quality review of documents (QRD) Adopted by CVMP and CMDv for release for consultation Start of public consultation End of consultation (deadline for comments)

October 2016 November 2016 25 November 2016 25 February 2017

8 Comments should be provided using this template.The completed comments form should be sent to [email protected] 9 Keywords

Pictograms, target species

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

13

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP)

14

Table of contents

15

1. Introduction ............................................................................................ 3

16

2. Definitions ............................................................................................... 3

17

3. General characteristics of pictograms ..................................................... 3

18

4. Requirements for pictograms taken from Annex 1 .................................. 4

19

4.1. Using pictograms from Annex 1 to substitute text on the packaging ........................... 4

20

4.1.1. Further considerations specific to pictograms of target species ................................ 4

21

4.2. Using pictograms from Annex 1 to accompany text on the packaging.......................... 4

22 23

4.3. Replacing existing pictograms by agreed pictograms from Annex 1 for approved products .................................................................................................................... 4

24

5. Mechanism to introduce pictograms from Annex 1 .................................. 4

25

6. Maintenance of pictograms in Annex 1 .................................................... 5

26

Annex 1 – Approved pictograms .................................................................. 6

27

Section 1 ................................................................................................................... 6

28

Section 2 ................................................................................................................... 8

10 11 12

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 2/8

29

1. Introduction

30

The safe and correct use of veterinary medicines depends on users being able to accurately read and

31

understand the information on the packaging. Therefore, the main purposes of the labelling are the

32

unambiguous identification, traceability and correct use of the veterinary medicinal product. Marketing

33

Authorisation Holders (MAH) must make best use of the available space on the packaging to ensure

34

that all the information is clear and legible, taking into consideration the typical environments or

35

situations in which the product will be used. The use of pictograms in general is optional. Pictograms

36

can be useful as long as the meaning and size of the graphic are clear. The need for a harmonised,

37

approved ‘catalogue’ of pictograms was identified:

38



to improve predictability of approval by regulators when the use of pictograms is proposed;

39



to embed and thereby improve the meaning of these harmonised pictograms for users of

40

veterinary medicines.

41

This guidance has been developed together with industry stakeholders. The use of pictograms from

42

Annex 1 as defined in this guidance will apply to the national authorisation procedures, including MRP

43

and DCP, as well as to the centralised procedure (EMA). The aim of the guidance is to outline the

44

approval requirements and process for two situations where either:

45



46 47

pictograms from section 1 of Annex 1 are proposed to substitute text on small, immediate packaging/blisters or;



pictograms from Annex 1 are proposed to accompany text on the labelling/package leaflet.

48

2. Definitions

49

Within this guidance, pictograms are defined as standard approved symbols that unambiguously

50

convey a piece of information or an instruction. These pictograms are distinctive to any other

51

images/graphic representations defining a Marketing Authorisation Holder e.g. logo, brand-specific

52

images.

53

3. General characteristics of pictograms

54

As a general requirement, pictograms should be clearly distinguishable from the background i.e. good

55

contrast. Pictograms taken from Annex 1 should specifically be printed in black and white, as shown.

56

The use of a highly glossy or metallic reflective colour is not recommended as it may affect clarity.

57

No visual effects such as shading should be used in the pictogram.

58

The size of the pictograms should be proportionate to the size of the printed surface/label. Pictograms

59

may not be less than 5 mm, which may be waived in exceptional circumstances for very small packs;

60

the approval of pictograms smaller than 5 mm will be a matter of assessment on a case-by-case basis.

61

The location of the pictograms should not negatively affect the readability of the mandatory

62

information on the packaging (e.g. if the pictogram is too close to text it can impact on readability).

63

Pictograms should exclude any element of a promotional nature.

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 3/8

64

4. Requirements for pictograms taken from Annex 1

65

4.1. Using pictograms from Annex 1 to substitute text on the packaging

66

If pictograms are used to substitute text on the packaging, it is considered compulsory to use those

67

provided in section 1 of Annex 1, i.e. the use of proprietary pictograms not in this ‘catalogue’ would

68

not be approved in the case of substitution of text.

69

The pictograms from section 1 of Annex 1 of this guidance can only be used to substitute text on

70

small immediate packaging units (as defined in the QRD product information template) and blisters.

71

Pictograms in section 2 1 of Annex 1 may not be used to substitute text, i.e. they may only be used in

72

addition to (alongside) the required text.

73

4.1.1. Further considerations specific to pictograms of target species

74

In particular for target species, pictograms cannot be used to replace text such as the age, sex or size

75

of the animal, therefore pictograms will always represent the species and not the sub-species.

76

Images/graphic representations that are not part of a brand-specific design, which could be interpreted

77

as target species on the outer packaging should be consistent with the approved pictograms used on

78

the immediate packaging as listed in section 1 of Annex 1, as well as consistent with the content of

79

the product information, in order to avoid confusion to the user.

80

4.2. Using pictograms from Annex 1 to accompany text on the packaging

81

As a general principle, the pictograms in Annex 1 may be included on the labelling/package leaflet in

82

addition to (alongside) the corresponding text that they are representing.

83 84

4.3. Replacing existing pictograms by agreed pictograms from Annex 1 for approved products

85

To ensure harmonisation and to establish a common understanding of pictograms by the user, it would

86

be preferable that any existing pictogram currently authorised as a substitution for text is replaced by

87

an approved pictogram from section 1 of Annex 1. Where existing pictograms are currently used

88

alongside the text that they represent, it is equally encouraged to replace them with an approved

89

pictogram from Annex 1 using the mechanisms described in section 5.

90

5. Mechanism to introduce pictograms from Annex 1

91

For new marketing authorisation applications, any proposed use of pictograms from Annex 1 should be

92

indicated in the product information within the initial submission or as soon as possible during the

93

ongoing procedure. For authorised products, requests to make use of pictograms from Annex 1 can be

94

made during another procedure affecting the product information i.e. when the product information is

95

‘open’ for review in the context of another procedure. Alternatively, a stand-alone variation application

96

may be introduced using classification C.II.6.b 2 (Type IB).

1

Section 2 is currently empty at the time of publication

2

Variation classification guideline 2013/C 223/01: link

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 4/8

97

In order to indicate its intended use to assessors, any pictogram should be inserted within the product

98

information, as follows:

99



If substitution of text by a pictogram from section 1 of Annex 1 is proposed (N.B. substitution

100

only currently possible for small immediate packaging units/blisters), insert the pictogram

101

within the respective section of Annex IIIA (Labelling) in the product information (QRD)

102

template without the accompanying text. Furthermore each pictogram from section 1 of

103

Annex 1 used as a substitution to text on small immediate packaging units/blisters should also

104

appear in the relevant section of the package leaflet, both in Annex IIIB of the product

105

information (QRD) template (and on the printed leaflet), close to the text it substitutes on the

106

small immediate packaging unit/blister, to reinforce and clarify the meaning of the pictogram.

107 108



If a pictogram is intended for use in addition to the text, insert the pictogram with the accompanying text within the respective section(s) of the product information (QRD) template.

109

6. Maintenance of pictograms in Annex 1

110

Requests for new pictograms (currently limited to the category of target species at the time of

111

publication), should be endorsed within industry associations where possible and then submitted to

112

both the CMDv and QRD secretariats for regulatory approval: [email protected] and

113

[email protected]. The newly-requested pictogram must be approved by these regulatory bodies

114

before its use in any submission under the terms of this guidance.

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 5/8

115

Annex 1 – Approved pictograms

116

Section 1 Target species Species

Pictogram

Location of image to download

Pig Link

Cattle Link

Sheep Link

Chicken Link

Rabbit Link

Horse Link

Goat Link

Dog Link

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 6/8

Species

Pictogram

Location of image to download

Cat Link

Turkey Link

Goose Link

Duck Link Fish Link

117

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 7/8

118

Section 2

119

This section is currently empty at the time of publication.

QRD guidance on the use of approved pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP) and decentralised procedures (DCP) EMA/752627/2016

Page 8/8

Draft QRD guidance on the use of approved pictograms on the ...

Nov 25, 2016 - The safe and correct use of veterinary medicines depends on users being able to accurately read and. 30 understand the information on the ...

201KB Sizes 26 Downloads 203 Views

Recommend Documents

Guidance notes on the use of VeDDRA ... - European Medicines Agency
Jun 15, 2017 - account when analysing adverse event data. In general it is preferable to avoid coding the same or similar clinical signs multiple times (e.g. ...

Draft Regulations on the use of Television White Spaces.pdf ...
INDEPENDENT COMMUNICATIONS AUTHORITY OF SOUTH AFRICA. NOTICE 283 OF 2017 283 Electronic Communications Act (36/2005): Hereby issues a ...

Draft concept paper on guidance for the collection of data on ...
Jul 13, 2016 - The lessons learnt during the trial on the collection of antimicrobial .... physical meeting will take place in 2016 and Adobe Connect meetings ...

Detailed guidance on the electronic submission of information on ...
Apr 19, 2017 - basis in line with the requirements and business processes described in this ...... to support data analytics and business intelligence activities; ...

Detailed guidance on the electronic submission of information on ...
Apr 19, 2017 - marketing authorisation holders to the European Medicines Agency in accordance with Article .... Pharmacovigilance enquiry email (AP.7) .

External guidance on the implementation of the European Medicines ...
Apr 12, 2017 - Template cover letter text: “Redaction Proposal Document” package . ...... should be redacted, e.g. name, email, phone number, signature and ...

Summary of changes to the 'External guidance on the implementation ...
Apr 12, 2017 - indication application submitted in the context of regulatory procedures not ... are able to identify validation non-compliance at an early stage. 2.

External guidance on the implementation of the European Medicines ...
12 Apr 2017 - External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use. EMA/90915/2016. Page 57/100. •. Information on scientific advice received from a

External guidance on the implementation of the European Medicines ...
Apr 12, 2017 - Page 2/100 ..... Information that is already in the public domain or publicly available – Rejection ..... and on the free movement of such data.

Presentation - Optimising the guidance on significant benefit ...
Apr 25, 2017 - Industry stakeholder platform on research and development support. Presented by Matthias Hofer on 25 ... authorisation application. Page 2. Orphan environment after 16 years of EU orphan legislation. Recent developments ...

Concept paper on the need for revision of the Note for Guidance on ...
Jul 21, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 .... It is expected that the revised Guideline will be helpful in designing state of the art clinical

External Guidance on the implementation of Policy 0070 - European ...
Sep 22, 2017 - Medicines Agency policy on the publication of clinical data .... Marketing authorisation transfers . ...... 9 For reports which present analysis of data collected from multiple studies, the applicant/MAH should include the.

Concept paper on the need for revision of the Note for Guidance on ...
Jul 21, 2016 - domains, e.g. cognition, are paramount across CNS disorders and warrant ... acceptance of the diagnostic and assessment tools available (7).

Guidance-Material-on-Comparison-of-Surveillance-Technologies ...
Page 2 of 47. Guidance Material on Surveillance Technology Comparison. Edition 1.0 September 2007 Page 2. TABLE OF CONTENTS. 1. Introduction.

Draft guideline on the clinical investigation of medicinal products for ...
Jun 23, 2016 - From a regulatory point of view, the following goals of a therapy can be .... 360 multidimensional scales are preferred over specific physical QoL ...

Draft guideline on the higher-tier testing of veterinary medicinal ...
Jul 25, 2016 - Endpoints include adult mortality, and the number and age stage of. 155 ... species are active in the region hosting the study (typically spring).

Draft guideline on equivalence studies for the demonstration of ...
Mar 23, 2017 - pharmacodynamic endpoints in the demonstration of therapeutic equivalence for locally applied, locally. 41 acting gastrointestinal products.

Attitudes of South African environmentalists on the domestic use of ...
Mar 18, 2009 - ABSTRACT. The paucity of literature on the perceptions and attitudes of South Africans on recycling, reusing, and reducing the number of resources used suggests the need for an exploration of these environmental issues. The current ene

Attitudes of South African environmentalists on the domestic use of ...
Mar 18, 2009 - ABSTRACT. The paucity of literature on the perceptions and attitudes of South Africans on recycling, reusing, and reducing the number of resources used suggests the need for an exploration of these environmental issues. The current ene

Draft agreement and draft decision on workstreams 1 and 2 of the Ad ...
Nov 6, 2015 - on the basis of the best available [and universally recognized] scientific ... Re-issued on 10 November 2015 due to technical errors in some of the .... technology and capacity-building by developed country Parties. ..... maintained by

European Medicines Agency practical guidance on the application ...
EMA/233564/2014 - Rev. 2. Procedure Management and Business Support Division. European Medicines Agency ... procedure: http://www.hma.eu/293.html ...

On the use of gradual densesparse discretizations in ...
SUMMARY. A key factor to success in implementations of real time optimal control, such as receding horizon control. (RHC), is making efficient use of computational resources. The main trade-off is then between efficiency and accuracy of each RHC iter

On the use of perceptual Line Spectral pairs ...
India Software Operations Ltd, Bangalore, India. Goutam Saha received his BTech and PhD Degrees from ... are very popular especially in VoIP communication. LSFs are also successfully introduced in speaker recognition task ... A comparison is also sho